Depressive Symptoms in a General Population: Associations with Obesity, Inflammation, and Blood Pressure

Table 3

Logistic regression analysis for the association of certain parameters with individuals consulting a physician, by gender.

	Total		Men		Women
	OR 95% CI		OR 95% CI		OR 95% CI
Model 1	184/1919^†		42/963^†		142/956^†
Female gender	3.98	2.76; 5.76
Age, 11 years	0.95	0.79; 1.12	1.18	0.88; 1.61	0.86	0.70; 1.06
Body mass index, 5 kg/m^2	1.07	0.93; 1.24	0.92	0.62; 1.36	1.10	0.94; 1.29
Systolic b. pressure, 20 mmHg	0.75	0.63; 0.92	0.80	0.56; 1.17	0.75	0.62; 0.94
Model 2	147/1594^†		36/822^†		111/772^†
Female gender	3.39	2.02; 5.68
Age, 11 years	0.91	0.75; 1.10	1.09	0.76; 1.56	0.84	0.66; 1.06
Body mass index, 5 kg/m^2	1.05	0.89; 1.23	0.94	0.61; 1.46	1.07	0.89; 1.28
Systolic b. pressure, 20 mmHg	0.75	0.62; 0.94	0.75	0.51; 1.13	0.79	0.62; 1.00
Fasting glucose, 40 mg/dL	0.96	0.82; 1.17	1.08	0.79; 1.43	0.92	0.76; 1.17
Current versus never smoking	0.80	0.40; 1.60	0.97	0.40; 2.35	0.95	0.25; 3.59
Antihypert. drug use, yes/no	1.23	0.82; 1.85	1.99	0.91; 4.34	1.05	0.65; 1.68
Lipid-lower. drug use, yes/no	0.92	0.48; 1.75	0.90	0.26; 3.15	0.90	0.43; 1.90

^†number of consulters/total number.
Antihypertensive/lipid-lowering drug usage in 523/136 men and women, respectively.
Significant values are highlighted in boldface.